Illumina Other Non-Current Liabilities decreased by 2.2% to $352.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from $344.00M to $352.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 3.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $238.00M | $1.09B | $915.00M | $845.00M | $853.00M | $613.00M | $649.00M | $654.00M | $702.00M | $555.00M | $620.00M | $642.00M | $331.00M | $313.00M | $339.00M | $344.00M | $348.00M | $334.00M | $360.00M | $352.00M |
| QoQ Change | — | +355.9% | -15.7% | -7.7% | +0.9% | -28.1% | +5.9% | +0.8% | +7.3% | -20.9% | +11.7% | +3.5% | -48.4% | -5.4% | +8.3% | +1.5% | +1.2% | -4.0% | +7.8% | -2.2% |
| YoY Change | — | — | — | — | +258.4% | -43.5% | -29.1% | -22.6% | -17.7% | -9.5% | -4.5% | -1.8% | -52.8% | -43.6% | -45.3% | -46.4% | +5.1% | +6.7% | +6.2% | +2.3% |